Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05965583
PHASE1

A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 1815368 in the Blood

Sponsor: Boehringer Ingelheim

View on ClinicalTrials.gov

Summary

The main objective of this trial is to investigate the effect on the exposure of BI 1815368 in plasma when given as oral single dose together with multiple oral doses of itraconazole (Test, T) as compared to when given alone as oral single dose (Reference, R).

Official title: Effect of Itraconazole on the Pharmacokinetics of a Single Oral Dose of BI 1815368 in Healthy Male Subjects (an Open-label, Two-period Fixed-sequence Design Study)

Key Details

Gender

MALE

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

14

Start Date

2023-08-02

Completion Date

2023-10-24

Last Updated

2026-05-12

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

BI 1815368

BI 1815368

DRUG

Itraconazole

Itraconazole

Locations (1)

Humanpharmakologisches Zentrum Biberach

Biberach, Germany